Azepinoindole derivatives as pharmaceutical agents

Details for Australian Patent Application No. 2006325815 (hide)

Owner Exelixis, Inc.

Inventors Baik, Taegon; Khoury, Richard George; Nuss, John M.; Ma, Sunghoon; Martin, Richard; Chan, Diva Sze-Ming; Busch, Brett B.; Flatt, Brenton T.; Mohan, Raju; Gu, Xiao Hui; Parks, Jason Jevious; Buhr, Chris A.; Lara, Katherine; Jammalamadaka, Vasu; Wang, Tie Lin; Wang, Longcheng; Wu, Jason H.; Xu, Wei; Yeung, Bryan K. S.

Agent Davies Collison Cave

Pub. Number AU-B-2006325815

PCT Pub. Number WO2007/070796

Priority 60/750,679 15.12.05 US; 60/750,634 15.12.05 US

Filing date 12 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 5 July 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/407 - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 3/00 Drugs for disorders of the metabolism

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/070796 Priority application(s): WO2007/070796

5 July 2012 Application Accepted

  Published as AU-B-2006325815

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006325818-Method for deriving a wellness related index for a food composition

2006325809-Self-sensing stents, smart materialsbased stents, drug delivery systems, other medical devices, and medical uses for piezo-electric materials